Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimetabolites.

A P Chen1, J L Grem

  • 1National Cancer Institute, Bethesda, Maryland.

Current Opinion in Oncology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

This research clarifies how cancer drugs like fluorouracil, methotrexate, and cytarabine work and how resistance develops. Understanding drug interactions and pharmacology helps minimize toxicity while maximizing therapeutic effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical analysis of 12 cases of ovarian yolk sac tumor].

Zhonghua fu chan ke za zhi·2024
Same author

[Superior oblique muscle injury during sino-nasal endoscopic surgery: two cases report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2024
Same author

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

NPJ precision oncology·2022
Same author

Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830].

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

[Primary osteosarcoma of left atrium: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2021
Same author

[Effect of GPX4 on proliferation and metastasis of renal clear cell carcinoma and its relationship with expression of IGF-1R and COX-2].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2019
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Antimetabolites such as fluorouracil, methotrexate, and cytarabine are crucial in cancer therapy.
  • Understanding the molecular mechanisms of drug sensitivity and resistance is essential for optimizing treatment outcomes.

Purpose of the Study:

  • To elucidate the determinants of sensitivity and mechanisms of resistance to key antimetabolites.
  • To clarify the regulation of target enzyme expression for these drugs.
  • To inform clinical trial design and therapeutic strategies.

Main Methods:

  • Review of recent research findings on antimetabolite action and resistance.
  • Analysis of advancements in analytical methodologies for enzyme quantitation.
  • Evaluation of data on drug interactions and clinical pharmacology.

Related Experiment Videos

Main Results:

  • Progress in understanding the complex regulation of target enzyme expression.
  • Development of analytical methods for quantifying thymidylate synthase.
  • Insights into drug interactions guiding dose and schedule optimization.
  • Identification of strategies to minimize toxicity while maintaining efficacy.

Conclusions:

  • Enhanced understanding of antimetabolite mechanisms improves therapeutic strategies.
  • Advances in analytical methods and pharmacology aid in personalized cancer treatment.
  • Future research can leverage these findings to refine drug regimens and reduce side effects.